A Randomized, Single‐Center, Double‐Blind, Controlled Case Study Evaluating Procedure Pairing of a Neurocosmetic Postprocedure Cream With Radiofrequency Microneedling for Facial Rejuvenation
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16622 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von McKenzie E Maloney und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Georgia, Augusta University, Augusta, Georgia, USA. Hauptthemen laut MEDLINE: Rejuvenation, Skin Aging, Needles, Skin Cream. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Revision Skincare, LLC.
Abstract (Originalsprache)
Background
Radiofrequency (RF) microneedling produces patient discomfort which deters patients from completing the recommended treatment series.
Objective
The primary objective was to determine the tolerability, safety, and efficacy of a neurocosmetic postprocedure cream post‐RF microneedling in reducing patient discomfort and enhancing recovery across the length of the study and, secondarily, to evaluate against a leading comparator. The third objective was to evaluate the efficacy of the neurocosmetic on self‐perceived improvement and objective grading. Materials and Methods An Institutional Review Board (IRB) approved, fourteen‐day, randomized, single‐center, double‐blind, controlled clinical case study was conducted with 11 healthy female subjects, 6 randomized to the neurocosmetic and 5 to the comparator cell. Following a 7‐day washout period, subjects received RF microneedling (face and neck) and applied the postprocedure cream twice daily for 7 days. Objective and subjective tolerability, self‐assessments, and clinical photography were performed immediately postprocedure, 24 h, three and seven days following the procedure.
Results
The neurocosmetic was tolerable and safe. Erythema and stinging immediately decreased postprocedure, postneurocosmetic application. After 24 h, 83% favorably agreed the neurocosmetic “reduced irritation on the skin post‐procedure,” and after 7 days, 100% favorably agreed “experience with the product was positive and I would be interested in returning for a second treatment.” The neurocosmetic reduced skin tone redness in the face and neck faster and to a greater degree when measured against a comparator.
Conclusion
The neurocosmetic postprocedure cream improved patient discomfort and enhanced recovery when used immediately post‐RF microneedling and after 7 days. IRB Protocol Number Pro00064211
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical College of Georgia, Augusta University, Augusta, Georgia, USA.
- Revision Skincare, Irving, Texas, USA.
- Gold Skin Center, Tennessee Clinical Research Center, Nashville, Tennessee, USA.
ORCID-Profile: McKenzie E Maloney, Alisar S Zahr, Michael H Gold
Förderung
- Revision Skincare, LLC
Zitieren
APA
Maloney, M. E., Iglesia, S., Kononov, T., Zahr, A. S., & Gold, M. H. (2024). A Randomized, Single‐Center, Double‐Blind, Controlled Case Study Evaluating Procedure Pairing of a Neurocosmetic Postprocedure Cream With Radiofrequency Microneedling for Facial Rejuvenation. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16622
Vancouver
Maloney ME, Iglesia S, Kononov T, Zahr AS, Gold MH. A Randomized, Single‐Center, Double‐Blind, Controlled Case Study Evaluating Procedure Pairing of a Neurocosmetic Postprocedure Cream With Radiofrequency Microneedling for Facial Rejuvenation. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16622
BibTeX
@article{Maloney2024,
author = {Maloney, McKenzie E and Iglesia, Sofia and Kononov, Tatiana and Zahr, Alisar S and Gold, Michael H},
title = {A Randomized, Single‐Center, Double‐Blind, Controlled Case Study Evaluating Procedure Pairing of a Neurocosmetic Postprocedure Cream With Radiofrequency Microneedling for Facial Rejuvenation},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16622}
}
EUVIMED